Experts Rank 10 Biotechnologies to Improve Global Health


TORONTO - Researchers at the University of Toronto's Joint Centre for Bioethics has determined 10 genomic and other biotechnologies that could significant impact global health within 10 years.

These include:

  • Molecular technologies for affordable, simple diagnosis of infectious disease
  • Recombinant technologies to develop vaccines against infectious diseases
  • Technologies for more efficient drug and vaccine delivery systems

Technologies for environmental improvement (sanitation, clean water, bioremediation)

  • Sequencing pathogens genomes to understand their biology and to identify new antimicrobials
  • Female-controlled protection against sexually transmitted disease, both with and without contraceptive effect
  • Bioinformatics to identify drug targets and to examine pathogen-host interaction
  • Genetically modified crops with increased nutrients to counter specific deficiencies
  • Recombinant technology to make therapeutic products (insulin, interferons) more affordable
  • Combinatorial chemistry for drug discovery.

"Current inequities in global health present major ethical challenges to the international community<' says centre director Peter Singer, MD. "Genomics is described as a powerful new wave of health related life sciences energized by the human genome project. This study ranks the most promising tools being created by harnessing this knowledge, offering unprecedented opportunities to address the growing health divide between rich and poor countries."

For more information, visit:

Related Videos
Association for the Health Care Environment (Logo used with permission)
Woman lying in hospital bed (Adobe Stock, unknown)
Photo of a model operating room. (Photo courtesy of Indigo-Clean and Kenall Manufacturing)
Washington, USA, US Treasury Department and Inspector General Office.    (Adobe Stock File 210945332 by Brian_Kinney)
A plasmid is a small circular DNA molecule found in bacteria and some other microscopic organisms. (Adobe Stock 522876298 by Love Employee)
Peter B. Graves, BSN, RN, CNOR, independent perioperative, consultant, speaker, and writer, Clinical Solution, LLC, Corinth, Texas; Maureen P. Spencer, M.Ed, BSN, RN, CIC, FAPIC, infection preventionist consultant, Infection Preventionist Consultants, Halifax, Massachusetts; Lena Camperlengo, DrPH, MPH, RN, Senior Director, Premier, Inc, Ocala, Florida.
Maddison B. Stone, MPH, CIC, LSSGB, senior infection preventionist, JPS Health Network, Fort Worth, Texas; and Jordan M. Chiasson, PharmD, BCIDP, clinical pharmacist - antimicrobial stewardship, JPS Health Network, Fort Worth, Texas
Central line catheter (Adobe Stock, unknown)
UV-C Robots by OhmniLabs.  (Photo from OhmniLabs website.)
Surgery (Adobe Stock, unknown)
Related Content